Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

12.13
Delayed Data
As of Feb 05
 +2.00 / +19.74%
Today’s Change
8.32
Today|||52-Week Range
23.30
-9.75%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close10.13
Today’s open10.08
Day’s range9.51 - 14.59
Volume4,673,846
Average volume (3 months)818,863
Market cap$593.4M
Dividend yield--
Data as of 02/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-34.37%
Earnings growth (next 5 years)+94.00%
Revenue growth (last year)+915.43%
P/E ratio53.9
Price/Sales3.44
Price/Book7.31

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.95-4.95%
SRPTSarepta Therapeutics...-0.01-0.08%
CTMXCytomX Therapeutics ...-0.73-4.72%
TBPHTheravance Biopharma...-0.01-0.06%
Data as of 02/05/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)$0.06
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers